abstract |
The present invention provides a melanin-concentrating hormone receptor antagonist, which is a compound of formula (I) wherein R, R, R, R, L, R, R and R are defined in the description of the present invention, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diastereomers of the compound, suitable for the treatment of obesity and related diseases. |